CILR- Tenure Track Assistant or Associate Professor
Location: Philadelphia, Pennsylvania
Type: Full Time
Academic / Research
College / University
Internal Number: -
Tenure Track Assistant or Associate Professor
Center for Inflammation & Lung Research (CILR)
Lewis Katz School of Medicine, Temple University
The Center for Inflammation & Lung Research, Lewis Katz School of Medicine at Temple University located in Philadelphia, PA, invites applications for a full time, tenure-track appointment at the Associate or Assistant Professor level. The CILR is undergoing an expansion, and we are currently recruiting a faculty investigator. Faculty candidates will be considered in all areas of immunology, physiology, biochemistry and/or molecular biology with an interest in the pathogenesis of lung inflammation. The successful candidate will also be expected to contribute to the development of Fellows in Pulmonary and Critical Care Medicine. The position will be supported by a competitive start up package, and academic rank and salary will be commensurate with qualifications and experience.
PhD, or equivalent degree
Post-doctoral experience, excellent communications skills and a record of productivity in the study of inflammatory disease states.
Candidates at the Assistant Professor level should have federal funding, and a substantial trajectory toward developing a rigorous, stable externally funded research program.
Candidates at the Associate Professor level should have a national scientific reputation, current research funding and a history of mentorship and leadership.
Candidates should be eager to participate in a highly collaborative environment, which includes significant interactions with clinical research investigators.
Center for Inflammation & Lung Research
The Center for Inflammation and Lung Research (CILR) is composed of basic, pre-clinical, translational and clinical researchers who are interested in the pathogenesis of lung disease, and other inflammatory disease states. Investigators in the CILR study both acute and chronic inflammatory disease using a combination of in vitro and animal model systems, as well as patients being seen by physicians in the Department of Thoracic Medicine and Surgery. The investigators in CILR are highly collaborative and strive to conduct their research studies using multidisciplinary approaches to study the immunology, physiology, pharmacology, and pathology of inflammatory diseases.
Lewis Katz School of Medicine
LKSOM, established in 1901, is one of the nation’s leading medical schools and Pennsylvania’s first co-educational medical school. Each year, the School educates approximately 840 medical students and 140 graduate students. LKSOM has attained a national reputation for training humanistic clinicians and biomedical scientists Based on its level of funding from the National Institutes of Health, LKSOM is the second-highest ranked medical school in Philadelphia and the third-highest in Pennsylvania. According to U.S. News & World Report, LKSOM is among the top 10 most-applied-to medical schools in the nation. It is fully accredited by the Liaison Committee on Medical Education. It employs 550 full-time and 50 part-time faculty members, in addition to more than 1,000 employees. The school’s home base in Philadelphia is a spectacular 11-story, 480,000 square-foot medical education and research building that feature state-of-the-art facilities and technologies for medical education and research. With specialized research centers focused on population health, metabolic disease, cancer, heart disease and other strategic priorities, the school conducts investigations to break new ground – and trains future generations of researchers to follow suit. Fully accredited, LKSOM takes pride in the excellence of its teaching, service and research programs.
Temple University, a comprehensive state-related research university, is the 28th largest university in the United States, and is home to a diverse group of students and faculty. Temple University is in the top tier of R1 Carnegie Classification of Institutions of Higher Education. Since 1965, Temple has been one of three state-related research universities in Pennsylvania. Four of Temple's seven Pennsylvania locations are in Philadelphia and the University continues to expand. Temple University is the 6th largest provider of professional education and includes Schools of Medicine, Pharmacy, Podiatry, Law, and Dentistry. The university also has several long-established locations abroad; Temple University Japan (TUJ) and Temple University Rome.
In order to be considered for this position, you must complete an online application at https://bit.ly/3OmBxCv by June20th, 2022. Your application will not be considered complete until you have submitted all of the required documents and information. All documents must be in PDF format.
Application materials should include a cover letter stating area of expertise and qualifications; a current curriculum vitae; synopses of research and teaching experience/interests; and the names of three references. A statement describing participation in activities that promote diversity and inclusion and/or plans to make future contributions is strongly encouraged.
Please address your application to: Thomas J. Rogers, PhD, Director and Professor, Center for Inflammation Lung and Research, and Professor of Microbiology Immunology and Inflammation/Center for Substance Abuse Research/Fels Cancer Institute for Personalized Medicine; C/O Jessica Vega, Sr. Physician/Faculty Recruiter, Lewis Katz School of Medicine at Temple University.
We are especially interested in qualified candidates from diverse backgrounds and under-represented groups. For more information about our commitment to diversity at the Lewis Katz School of Medicine, please visit OHEDI.
COVID-19 vaccinations are required for employment at Temple University, unless granted a religious or medical exemption (see www.temple.edu/coronavirus)
Lewis Katz School of Medicine at Temple University is an Affirmative Action/Equal Opportunity Employer and strongly encourages applications from women, minorities, veterans, and persons with disabilities.